This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reuner, K. H. Articles by Patscheke, H. Search for Related Content PubMed PubMed Citation Articles by Reuner, K. H. Articles by Patscheke, H. Pubmed/NCBI databases Substance via MeSH

(Stroke. 1998;29:1765-1769.)
© 1998 American Heart Association, Inc.

Original Contributions

Prothrombin Gene G₂₀₂₁₀A Transition Is a Risk Factor for Cerebral Venous Thrombosis

Karl H. Reuner, MD; Andreas Ruf, MD; Armin Grau, MD; Henning Rickmann, MD; Erwin Stolz, MD; Eric Jüttler, MD; Karl-F. Druschky, MD; Heinrich Patscheke, MD

From the Institute for Medical Laboratory Diagnostics, Klinikum Karlsruhe (K.H.R., A.R., H.P.), Department of Neurology, University of Heidelberg (A.G., E.J.), Department of Neurology, Klinikum Karlsruhe (H.R., K.-F.D.), and the Department of Neurology, University of Gießen (E.S.), Germany.

Correspondence to Dr Karl H. Reuner, Institute for Medical Laboratory Diagnostics, Klinikum Karlsruhe, Moltkestr 90, D-76133 Karlsruhe, Germany.

Background and Purpose—It has been recently reported that a GA transition at nucleotide position 20210 in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of deep venous thrombosis. To date, it is unknown whether this polymorphism also represents a risk factor for cerebral venous thrombosis (CVT).

Methods—Venous blood samples were collected from 45 patients with CVT and from 354 healthy blood donors as controls. A second control group consisted of 131 subjects with acute ischemic stroke or transient ischemic attack (TIA). Genomic DNA was isolated from peripheral blood leukocytes. Amplification of DNA was performed by polymerase chain reaction (PCR). The GA transition at nucleotide position 20210 of the prothrombin gene was detected by allele-specific restriction digestion.

Results—The G₂₀₂₁₀A transition in the prothrombin gene was found in a heterozygous form in 4 of 45 patients with CVT (8.9%) and in 8 of 354 healthy control subjects (2.3%). This difference was statistically significant (P=0.010). The G₂₀₂₁₀A transition increased the relative risk for CVT approximately 5-fold (age-adjusted odds ratio 5.7; 95% CI 1.5 to 21.5). In contrast, in the group of patients with acute cerebral ischemia, only 3 of 131 subjects (2.3%) were heterozygous for the G₂₀₂₁₀A transition, which corresponded to the prevalence in the group of healthy blood donors.

Conclusions—The recently described G₂₀₂₁₀A transition in the 3'-untranslated region of the prothrombin gene is an inherited risk factor for CVT but obviously not for acute ischemic stroke or TIA.

Key Words: coagulation • hereditary disease • thrombophilia • sinus thrombosis

This article has been cited by other articles:

				E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF]

				E. M. Wysokinska, W. E. Wysokinski, R. D. Brown, K. Karnicki, I. Gosk-Beirska, D. Grill, and R. D. McBane II Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis Neurology, February 19, 2008; 70(8): 627 - 633. [Abstract] [Full Text] [PDF]

				B. Voetsch, R. C. Jin, C. Bierl, L. Deus-Silva, E. C.S. Camargo, J. M. Annichino-Bizacchi, D. E. Handy, and J. Loscalzo Role of Promoter Polymorphisms in the Plasma Glutathione Peroxidase (GPx-3) Gene as a Risk Factor for Cerebral Venous Thrombosis Stroke, February 1, 2008; 39(2): 303 - 307. [Abstract] [Full Text] [PDF]

				K. H. Reuner, E. Jenetzky, A. Aleu, F. Litfin, P. Mellado, M. Kloss, E. Juttler, A. J. Grau, H. Rickmann, H. Patscheke, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis Neurology, January 8, 2008; 70(2): 129 - 132. [Abstract] [Full Text] [PDF]

				F. Dentali, M. Crowther, and W. Ageno Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis Blood, April 1, 2006; 107(7): 2766 - 2773. [Abstract] [Full Text] [PDF]

				J. Stam Thrombosis of the Cerebral Veins and Sinuses N. Engl. J. Med., April 28, 2005; 352(17): 1791 - 1798. [Full Text] [PDF]

				G. Sebire, B. Tabarki, D. E. Saunders, I. Leroy, R. Liesner, C. Saint-Martin, B. Husson, A. N. Williams, A. Wade, and F. J. Kirkham Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome Brain, March 1, 2005; 128(3): 477 - 489. [Abstract] [Full Text] [PDF]

				J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]

				C. Heller, A. Heinecke, R. Junker, R. Knofler, A. Kosch, K. Kurnik, R. Schobess, A. von Eckardstein, R. Strater, B. Zieger, et al. Cerebral Venous Thrombosis in Children: A Multifactorial Origin Circulation, September 16, 2003; 108(11): 1362 - 1367. [Abstract] [Full Text] [PDF]

				F. L Ruberg and J. Loscalzo Prothrombotic determinants of coronary atherothrombosis Vascular Medicine, November 1, 2002; 7(4): 289 - 299. [Abstract] [PDF]

				T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]

				B. Rizzato, F. Ferrante, A. Pisani, M. Diomedi, J. N. Fink, and D. L. McAuley Recurrent Cerebral Venous Thrombosis in a 24-Year-Old Puerperal Woman * Response Stroke, September 1, 2002; 33(9): 2148 - 2149. [Full Text] [PDF]

				A. Kao, D. Dlugos, J. V. Hunter, P. Mamula, and O. Thorarensen Anticoagulation Therapy in Cerebral Sinovenous Thrombosis and Ulcerative Colitis in Children J Child Neurol, July 1, 2002; 17(7): 479 - 482. [Abstract] [PDF]

				P. Madonna, V. de Stefano, A. Coppola, F. Cirillo, A. M. Cerbone, G. Orefice, and G. Di Minno Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke Stroke, January 1, 2002; 33(1): 51 - 56. [Abstract] [Full Text] [PDF]

				A. J. Catto Genetic aspects of the hemostatic system in cerebrovascular disease Neurology, September 1, 2001; 57(90002): S24 - 30. [Abstract] [Full Text]

				P. Madonna, V. De Stefano, A. Coppola, R. Albisinni, and A. M. Cerbone G20210A PRTH Gene Mutation and Other Trombophilic Polymorphisms in Patients With Cerebral Vein Thrombosis Stroke, July 1, 2000; 31 (7): 1785 - 1790. [Full Text] [PDF]

				M. J. Kupferminc, D. Yair, N. M. Bornstein, J. B. Lessing, and A. Eldor Transient Focal Neurological Deficits During Pregnancy in Carriers of Inherited Thrombophilia Stroke, April 1, 2000; 31(4): 892 - 895. [Abstract] [Full Text] [PDF]

				R. D. Rosenberg and W. C. Aird Vascular-Bed-Specific Hemostasis and Hypercoagulable States N. Engl. J. Med., May 20, 1999; 340(20): 1555 - 1564. [Full Text] [PDF]